Lincoln Alternative Strategies LLC's Ownership in Celularity Inc


2025-08-27SEC Filing SCHEDULE 13G (0001641172-25-025647)

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 1,230,769 shares of Class A Common Stock in Celularity Inc, representing 5.14% of the total outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over these shares. The shares were not acquired for the purpose of influencing the control of Celularity Inc. The filing was made under Rule 13d-1(c) and includes a certification that the shares are not held with the intent to change or influence the control of the issuer. The filing was signed by Stephen Temes, Managing Member, on behalf of Lincoln Alternative Strategies LLC.


Tickers mentioned in this filing:CELU